MedPath

NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES(PAKISTAN)

NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES(PAKISTAN) logo
πŸ‡΅πŸ‡°Pakistan
Ownership
Private
Established
1963-01-01
Employees
1K
Market Cap
-
Website
http://nicvd.org

Use of Export in Primary Percutaneous Coronary Intervention

Not Applicable
Recruiting
Conditions
Total Occlusion of Coronary Artery
Primary Percutaneous Coronary Intervention
ST-segment Elevation Myocardial Infarction (STEMI)
Interventions
Device: Balloon catheter
Device: Export Catheter
First Posted Date
2022-08-22
Last Posted Date
2024-03-22
Lead Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Target Recruit Count
300
Registration Number
NCT05510661
Locations
πŸ‡΅πŸ‡°

National Institute of Cardiovascular Diseases, Karachi, Sindh, Pakistan

Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction

Phase 4
Completed
Conditions
Heart Failure, Systolic
Interventions
First Posted Date
2022-05-24
Last Posted Date
2022-05-24
Lead Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Target Recruit Count
121
Registration Number
NCT05387967
Locations
πŸ‡΅πŸ‡°

National Institute of Cardiovascular Diseases, Karachi, Sindh, Pakistan

To Evaluate if Dexmedetomidine Infusion Provides Renal Protection in Patients Undergoing Coronary Artery Bypass Graft

Phase 2
Completed
Conditions
Acute Kidney Injury
Interventions
Drug: Normal Saline
First Posted Date
2022-05-16
Last Posted Date
2022-05-16
Lead Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Target Recruit Count
60
Registration Number
NCT05375188
Locations
πŸ‡΅πŸ‡°

NICVD Karachi, Karachi, Sindh, Pakistan

Ketorolac-an Option for Post Operative Pain Management After Elective Cardiac Surgery.

Phase 4
Completed
Conditions
Coronary Artery Disease
Post Operative Pain
Analgesia
Coronary Artery Bypass Grafting Surgery
Interventions
First Posted Date
2022-05-05
Last Posted Date
2022-09-30
Lead Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Target Recruit Count
60
Registration Number
NCT05361824
Locations
πŸ‡΅πŸ‡°

National Institute of Cardiovascular Diseases, Karachi, Sindh, Pakistan

Rivaroxaban in Left Ventricular Thrombus

Phase 4
Completed
Conditions
Left Ventricular Thrombus
Acute Coronary Syndrome
Interventions
First Posted Date
2021-07-21
Last Posted Date
2024-11-15
Lead Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Target Recruit Count
261
Registration Number
NCT04970576
Locations
πŸ‡΅πŸ‡°

National Institute of Cardiovascular Diseases, Karachi, Sindh, Pakistan

Steri-strips for Reducing Radial Artery Compression Duration

Not Applicable
Completed
Conditions
Acute Coronary Syndrome
Interventions
Device: Steri-strips
First Posted Date
2021-05-25
Last Posted Date
2022-02-16
Lead Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Target Recruit Count
204
Registration Number
NCT04900987
Locations
πŸ‡΅πŸ‡°

National Institute of Cardiovascular Diseases, Karachi, Sindh, Pakistan

Adrenaline for the Treatment of No-Reflow in Normotensive Patients

Phase 4
Completed
Conditions
No-Reflow Phenomenon
Acute Coronary Syndrome
Normotensive
Interventions
First Posted Date
2021-01-07
Last Posted Date
2021-05-21
Lead Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Target Recruit Count
201
Registration Number
NCT04699110
Locations
πŸ‡΅πŸ‡°

National Institute of Cardiovascular Diseases, Karachi, Sindh, Pakistan

Β© Copyright 2025. All Rights Reserved by MedPath